Search results

As part of the work underpinning the development of the UK Policy Framework for Health and Social Care Research - the replacement for the 4 Research Governance Frameworks (RGF) - the HRA conducted a number of exercises to obtain a better understanding of the current systems in place for research governance.

Our newsletter, HRA Latest, will keep you you up-to-date with the latest news and developments from across the organisation. If you haven't already, please subscribe to our newsletter.

Annual reports for Research Ethics Committees from April 2011 - 2012.

Annual reports for Research Ethics Committees from April 2012 - 2013.

Twitter users searching for #HRAtips can get advice on submitting studies for HRA Approval as part of a new campaign to help applicants avoid common mistakes in their research proposals.

The Annual NHS R&D Forum is taking place in Manchester on 15 - 16 May 2017 – the must-attend meeting of the year for those working in health and care research management, support and leadership.

It is with great sadness that we hear of the news of the death of a close friend of the Health Research Authority, Dr Richard Tiner. A former general practitioner in the South West of England for many years, Richard was medical director of the Association of British Pharmaceutical Industry from 1996 – 2009.

The HRA is encouraging researchers to take a more proportionate approach to the process of seeking consent for participation in research.

In response to requests, the Health Research Authority (HRA) has published a new brief leaflet setting out high level information about the HRA Approval process. It provides an overview, highlighting our aim to simplify and streamline the approval process.

The Department of Health (DH) and the Health Research Authority (HRA) have been working together to review the standard DH contract for NIHR funded research. From today research funded by an NIHR research programme will be able to receive payments for start-up in advance of ethical approval. This enables more rapid, efficient and streamlined set-up of research and quicker translation of research into patient benefit.

From 31 March 2016 HRA Approval will be the process for applying for approvals for all project-based research in the NHS led from England. For any new studies that are led from outside England but have English sites, the NHS permissions coordinating function of the lead nation will share information with the HRA Assessment team, who can issue HRA Approval for English sites and thereby retain existing compatibility arrangements.

A discussion paper entitled ‘When should placebo surgery as a control in clinical trials be carried out?’ has been published by contributors to a workshop held jointly by the Health Research Authority and the Nuffield Council on Bioethics in May 2015. The workshop brought together surgeons, patient representatives, regulators and research ethics committees to discuss issues surrounding the use of placebo surgery.

The Confidentiality Advisory Group (CAG) is looking to appoint new members to help it deliver its existing and future functions. The CAG provides the Health Research Authority (HRA) and the Secretary of State for Health (SofS) with independent expert advice about applications for access to confidential patient information. The work of the Group is challenging, but it is also immensely rewarding. Interviews will take place on Tuesday 15, Friday 18 and Monday 21 March 2016.

The Medicines and Healthcare products Regulatory Agency (MHRA) Innovation Office is the portal for all regulatory queries concerning regenerative medicines.